Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Anemia
100%
Cyclophosphamide
100%
Chronic Lymphocytic Leukemia
100%
Fludarabine
100%
Autoimmune Hemolytic Anemia
100%
Rituximab
100%
Rituximab Therapy
22%
Direct Antiglobulin Test
22%
Pure Red Cell Aplasia
22%
Lactate Dehydrogenase
11%
Additional Markers
11%
β2-microglobulin (β2-MG)
11%
Nineteen
11%
Haptoglobin
11%
Leukemia Patients
11%
Reticulocytosis
11%
Elevated Lactate
11%
IV Immunoglobulin
11%
Ciclosporin
11%
Indirect Hyperbilirubinemia
11%
Hemolytic Crisis
11%
Medicine and Dentistry
Anemia
100%
Cyclophosphamide
100%
B-Cell Chronic Lymphocytic Leukemia
100%
Evans Syndrome
100%
Fludarabine
100%
Rituximab
100%
Coombs Test
18%
Pure Red Cell Aplasia
18%
Immunoglobulin
9%
Cyclosporine
9%
Lactate Dehydrogenase
9%
Hyperbilirubinemia
9%
Hemolytic
9%
Reticulocytosis
9%
Haptoglobin
9%
Beta 2 Microglobulin
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclophosphamide
100%
Chronic Lymphatic Leukemia
100%
Fludarabine
100%
Anemia
100%
Rituximab
100%
Autoimmune Hemolytic Anemia
100%
Immunoglobulin Antibody
18%
Pure Red Cell Anemia
18%
Lactate Dehydrogenase
9%
Ciclosporin
9%
Immunoglobulin
9%
Haptoglobin
9%
Reticulocytosis
9%
Hyperbilirubinemia
9%
Beta 2 Microglobulin
9%
Neuroscience
Rituximab
100%
Cyclophosphamide
100%
Fludarabine
100%
Immunoglobulin Antibody
22%
Ciclosporin
11%
Intravenous Immunoglobulin
11%
Lactate Dehydrogenase
11%
Haptoglobin
11%
Beta 2 Microglobulin
11%